Indian regulatory approval for Transchem investment sends Bakkt stock up 3.42% in early session

Traders Union
All News
Financial News
Bakkt rises 3.42% to $9.23 today

Highlights

Bakkt secured Indian regulatory approval and completed a $9.4 million investment in Transchem Limited, expanding its cross-border capabilities.
This milestone solidifies Bakkt’s operational foothold in India, supporting its strategy to diversify and grow internationally.
BKKT/USD faces persistent bearish momentum with heavy selling pressure, trading below major averages and risk skewed toward a $8.09 downside over the next days.

Expansion strategy advances as Indian regulatory approval drives sentiment shift

Bakkt, Inc. has completed a key milestone by obtaining Indian regulatory approvals for its strategic investment in Transchem Limited, an action which enables cross-border market access and deepens operational presence in India. The company finalized payment for 47,500,000 warrants, representing an initial outlay of approximately $9.4 million, which demonstrates both commitment and financial capability to pursue expansion in the region. This regulatory clearance and investment execution highlight tangible progress in Bakkt’s plan to increase international reach and diversify growth avenues, creating a constructive backdrop for market sentiment.

Technical barriers limit upside as momentum signals remain bearish

BKKT is trading below its MA-20 ($9.65) and MA-50 ($10.59) on the hourly chart, as well as the MA-200 ($14.54) on the daily chart. The Ichimoku Kijun at $9.93 serves as immediate resistance. Intraday momentum indicators, including MACD and ADX, are signaling strong selling pressure, with the RSI at 33.05, CCI and BBP both on sell, and Stoch RSI in a neutral position. The Awesome Oscillator is also neutral, not providing additional directional bias. This alignment points to technical headwinds and limited upside momentum in the short term.

Low breakout odds as downside risk dominates near-term trading

Over the next 2–3 days, the anticipated price range for BKKT is $8.09 to $10.37, representing a typical volatility band relative to current levels. The probability of an upward breakout remains very low, with downside risk prevailing unless price action can reclaim resistance at $9.93. A bullish scenario would require a break above this resistance level, targeting the upper end of the range, while a bearish outcome could see BKKT slip below $8.09, potentially triggering further selling pressure.

Anton Kharitonov, expert at Traders Union, notes that Bakkt’s Indian regulatory approval and investment in Transchem show clear operational moves, but technical conditions remain weak. He observes that the stock is facing downside momentum and is trading below all key moving averages, with strong selling pressure confirmed by the indicators. Kharitonov believes resistance at $9.93 is crucial and sees risk of further declines unless this level is reclaimed. "Until we see BKKT regain $9.93, I remain defensive and would avoid any aggressive long positions here."

Earlier, analysts noted that Bakkt was demonstrating ongoing technical weakness, with limited prospects for immediate price recovery. The recent regulatory success in India introduces a new growth catalyst, but with technical headwinds persisting, traders should closely monitor the $9.93 resistance level for signs of a momentum shift.

Source of Data: BKKT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.